Cyclosporine lymphocyte level and lymphocyte count: new guidelines for tailoring immunosuppressive therapy.
Barbari
A
A
Nephrology and Transplantation Unit, Rizk Hospital, Beirut, Lebanon. lird@cyberia.net.lb
Stephan
A
A
Masri
M
M
Mourad
N
N
Kamel
G
G
Kilani
H
H
Karam
A
A
Daya
I A
IA
D001706:Biopsy; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D018655:Lymphocyte Count; D008214:Lymphocytes / Q000378:metabolism*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine